Piramal Pharma share price jumps 10.6% to ₹219.84
Key Highlights
Piramal Pharma share price rose to ₹219.84 at 09:19 IST. The company reported a net profit of ₹5 crore for Q2 FY27.
- Piramal Pharma rose 10.63% to ₹219.84 at 09:19 IST on 28 Oct 2026.
- so far was 3.07× its 20-session average.
- Q2 FY27 net profit: ₹5 crore.
- Nifty Pharma was −0.35%.
Figures as of: 09:19 IST, Wednesday 28 October 2026
Piramal Pharma Ltd. share price rose 10.63% to ₹219.84 at 09:19 IST on Wednesday 28 October 2026. The stock traded 3.07× the 20-session average volume during the session. The company filed Q2 FY27 results on Tuesday evening, and the share price rose on Wednesday morning. The reported net profit for the quarter was ₹5 crore.
Piramal Pharma share price today
| Price (09:19 IST) | ₹219.84 |
| Change from the previous close (₹198.72) | +₹21.12 (+10.63%) |
| Day’s range | ₹209.04 – ₹220.95 |
| Volume so far | 71.3 lakh shares |
| 20-session average daily volume | 23.2 lakh shares (volume so far is 3.07× that) |
| Closing prices of the previous 4 sessions | ₹191.07 – ₹198.72 |
| 52-week range (adjusted prices) | ₹132.30 – ₹231.93 |
| Price against that range | 5.2% below the high, 66.2% above the low |
| Market value at this price | ₹29,268 crore |
The stock traded between ₹209.04 and ₹220.95 during the morning session. Current volume reached 3.07× the 20-session average daily volume of 23.2 lakh shares. The price sits 5.2% below the 52-week high of ₹231.93.
What has been announced
| When (IST) | Filing |
|---|---|
| Tue 27 Oct, 9:06 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Tue 27 Oct, 9:04 pm | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Tue 27 Oct, 8:59 pm | Unaudited Financial Results ( And ) Of The Company For The Quarter Ended September 30 2026 |
| Tue 27 Oct, 8:53 pm | Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited Held On 27Th October 2026 |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| from operations | 2,617 | 2,044 | +28.05% | 2,270 | +15.29% |
| 82 | −46 | – | −7 | – | |
| Net profit | 5 | −99 | – | −69 | – |
| Net profit as a share of revenue | 0.19% | −4.85% | – | −3.06% | – |
Q2 FY27 revenue from operations reached ₹2,617 crore, which is 28.05% higher than a year earlier. Profit before tax for the quarter was ₹82 crore. The company reported a net profit of ₹5 crore for the period, compared to a net profit as a share of revenue of −4.85% a year earlier.
How Piramal Pharma compares with its sector
| Change today | |
|---|---|
| Piramal Pharma | +10.63% |
| Nifty Pharma | −0.35% |
| −0.77% | |
| Torrent Pharmaceuticals | −2.22% |
| Divi’s Laboratories | −0.90% |
| Zydus Lifesciences | −0.84% |
| Sun Pharmaceutical Industries | −0.66% |
The Nifty Pharma index was −0.35% while the Nifty 50 was −0.77%. Peer Torrent Pharmaceuticals was −2.22% and Divi’s Laboratories was −0.90%. Zydus Lifesciences was −0.84% and Sun Pharmaceutical Industries was −0.66%.
Piramal Pharma share price: FAQs
What is the Piramal Pharma share price today?
₹219.84 at 09:19 IST on Wednesday 28 October 2026, up ₹21.12 or 10.63% from the previous close of ₹198.72.
What were Piramal Pharma’s Q2 FY27 results?
Consolidated revenue from operations of ₹2,617 crore (+28.05% year on year) and net profit of ₹5 crore, for the quarter ended 30 September 2026.
When did Piramal Pharma announce the results?
The board meeting outcome was filed on Tue 27 Oct, 8:59 pm IST.
How is the Pharma sector doing today?
Nifty Pharma was −0.35% at 09:19 IST on Wednesday 28 October 2026, against +10.63% for Piramal Pharma.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.